梅斯健康:2023年報
Medsci Healthcare Rebounds to 2023 Profit
MedSci Healthcare (HKG:2415) rebounded to 2023 profit attributable to owners of 55.0 million yuan, or 0.08 yuan per share, from loss of 99.9 million yuan, or 0.21 yuan per share, the year earlier. The
Mace Health (02415) announced 2023 annual results, net profit of 55.42 million yuan
Mace Health (02415) announced results for the year ended December 31, 2023, with revenue of 349 million yuan (...
MEDSCI: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Metz Health (02415.HK) will hold a board meeting on March 28 to approve the full year results
GLONGHUI March 18 | Mace Health (02415.HK) announced that the company will hold a board meeting on March 28, 2024 to adopt the annual results of the company and its subsidiaries for the year ended 31 December 2023 and consider the proposed payment of a final dividend (if any).
MedSci Healthcare to Return to Profit in 2023
MedSci Healthcare Holdings (HKG:2415) expects an attributable profit of at least 50 million yuan for the year 2023, as compared to an attributable loss in 2022, the online professional physician platf
Is MedSci Healthcare Holdings Limited's (HKG:2415) ROE Of 1.7% Concerning?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business.
Hang Seng Healthcare Index rose 1.16%; Hanson Pharmaceuticals (03692) rose 6.61%
Jinwu Financial News | Hang Seng Healthcare Index rose 1.16%. Among the constituent stocks, Metz Health (02415) rose 8.1%, Hanson Pharmaceuticals (03692) rose 6.61%, Lepu Biotech (02157) rose 5.28%, minimally invasive robotics (02252) rose 3.98%, and Ping An Good Doctor (01833) rose 3.31%. The CDB Securities Research Report pointed out that although the short-term pharmaceutical industry has been adjusted due to the overall market situation, the industry has ushered in positive factors and changes in terms of policy, performance, valuation level, and position level. Continue to focus on the main line of innovation that has ushered in positive changes
MedSci Healthcare Holdings Limited's (HKG:2415) CEO Xinmei Li Is the Most Upbeat Insider, and Their Holdings Increased by 17% Last Week
Key Insights MedSci Healthcare Holdings' significant insider ownership suggests inherent interests in company's expansion 59% of the business is held by the top 2 shareholders Past performance of
MEDSCI: 2023 INTERIM REPORT
Metz Health has adopted a stock reward program
Metz Health (02415) announced that on September 19, 2023, the company has adopted a share award program.
MedSci Healthcare Holdings Limited (HKG:2415) Delivered A Weaker ROE Than Its Industry
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business.
Changes in Hong Kong stocks | Mace Health (02415) rose more than 14%, the Internet medical penetration rate still has a lot of room for improvement, and the online diagnosis and treatment circuit is expected to grow
Metz Health (02415) surged more than 14% in early trading, up 14.52% at press time to HK$5.6, with a turnover of HK$24.53 million.
Changes in Hong Kong stocks | Mace Health (02415) rose more than 19%, interim results, profit attributable to shareholders of 11.92 million yuan, turned a year-on-year loss into a profit
Metz Health (02415) rose more than 19%, up 19.34% at press time, to HK$6.11, with a turnover of HK$5.18 million.
MEDSCI: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Mace Health is profitable and expects profit attributable to mid-term shareholders to be about 10 million yuan
Mace Health (02415) announced that the Group expects to achieve profit attributable to shareholders of approximately RMB 10 million in the six months ending June 30, 2023, and net loss attributable to shareholders for the six months ending June 30, 2022. The Group is also expected to increase its adjusted net profit by approximately 10% to 20% compared to its adjusted net profit for the six months ended June 30, 2022. Adjusted net profit refers to the Group's net profit after deducting listing related expenses and loss in the fair value of convertible and redeemable preferred shares. The Group turned a loss into a profit and the increase in adjusted net profit was mainly due to the Group's provision of accurate omni-channel
MEDSCI: INSIDE INFORMATION POSITIVE PROFIT ALERT
Metz Health (02415.HK) plans to hold a board meeting on August 25 to approve interim results
Glonway August 15, 丨Metz Health (02415.HK) announced that the company will hold a board meeting on August 25, 2023 (Friday) to (including) consider and approve the Group's interim results for the six months ended June 30, 2023 and their publication, and consider the payment of interim dividends (if any).
MEDSCI: DATE OF BOARD MEETING
The Recent 8.9% Gain Must Have Brightened CEO Xinmei Li's Week, MedSci Healthcare Holdings Limited's (HKG:2415) Most Bullish Insider
Key Insights Insiders appear to have a vested interest in MedSci Healthcare Holdings' growth, as seen by their sizeable ownership 53% of the business is held by the top 2 shareholders Using data f
No Data